A carregar...
Disparities in Discontinuing Rosiglitazone Following the 2007 FDA Safety Alert
BACKGROUND: Responsiveness to the Food and Drug Administration (FDA) rosiglitazone safety alert, issued on May 21, 2007, has not been examined among vulnerable subpopulations of the elderly. OBJECTIVE: To compare time to discontinuation of rosiglitazone after the safety alert between black and white...
Na minha lista:
| Publicado no: | Med Care |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4807625/ https://ncbi.nlm.nih.gov/pubmed/26978569 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MLR.0000000000000502 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|